Molecular Determinants of the Ratio of Inert to Infectious Virus Particles

被引:57
作者
Klasse, P. J. [1 ]
机构
[1] Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med Coll, New York, NY 10021 USA
来源
MOLECULAR BASIS OF VIRAL INFECTION | 2015年 / 129卷
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; MURINE LEUKEMIA-VIRUS; DEFECTIVE INTERFERING PARTICLES; ENVELOPE GLYCOPROTEIN TRIMERS; NEWCASTLE-DISEASE VIRUS; INDIVIDUAL INFLUENZA-VIRUSES; BLOOD MONONUCLEAR-CELLS; HUMAN LYMPHOID-TISSUE; WILD-TYPE VIRUS; CD4(+) T-CELLS;
D O I
10.1016/bs.pmbts.2014.10.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ratio of virus particles to infectious units is a classic measurement in virology and ranges widely from several million to below 10 for different viruses. Much evidence suggests a distinction be made between infectious and infecting particles or virions: out of many potentially infectious virions, few infect under regular experimental conditions, largely because of diffusion barriers. Still, some virions are inert from the start; others become defective through decay. And with increasing cell- and molecular-biological knowledge of each step in the replicative cycle for different viruses, it emerges that many processes entail considerable losses of potential viral infectivity. Furthermore, all-or-nothing assumptions about virion infectivity are flawed and should be replaced by descriptions that allow for spectra of infectious propensities. A more realistic understanding of the infectivity of individual virions has both practical and theoretical implications for virus neutralization, vaccine research, antiviral therapy, and the use of viral vectors.
引用
收藏
页码:285 / 326
页数:42
相关论文
共 197 条
[1]   Functional Stability of Unliganded Envelope Glycoprotein Spikes among Isolates of Human Immunodeficiency Virus Type 1 (HIV-1) [J].
Agrawal, Nitish ;
Leaman, Daniel P. ;
Rowcliffe, Eric ;
Kinkead, Heather ;
Nohria, Raman ;
Akagi, Junya ;
Bauer, Katherine ;
Du, Sean X. ;
Whalen, Robert G. ;
Burton, Dennis R. ;
Zwick, Michael B. .
PLOS ONE, 2011, 6 (06)
[2]   Toward a more accurate quantitation of the activity of recombinant retroviruses: Alternatives to titer and multiplicity of infection (vol 74, pg 1258, 2000) [J].
Andreadis, S ;
Lavery, T ;
Davis, HE ;
Le Doux, JM ;
Yarmush, ML ;
Morgan, JR .
JOURNAL OF VIROLOGY, 2000, 74 (07) :3431-3439
[3]  
[Anonymous], COLD SPRING HARB PRO
[4]   CELLULAR PROTEINS BOUND TO IMMUNODEFICIENCY VIRUSES - IMPLICATIONS FOR PATHOGENESIS AND VACCINES [J].
ARTHUR, LO ;
BESS, JW ;
SOWDER, RC ;
BENVENISTE, RE ;
MANN, DL ;
CHERMANN, JC ;
HENDERSON, LE .
SCIENCE, 1992, 258 (5090) :1935-1938
[5]   GENE-THERAPY - INTRACELLULAR IMMUNIZATION [J].
BALTIMORE, D .
NATURE, 1988, 335 (6189) :395-396
[6]   HOMOLOGOUS INTERFERENCE BY ULTRAVIOLET-INACTIVATED NEWCASTLE DISEASE VIRUS [J].
BALUDA, MA .
VIROLOGY, 1957, 4 (01) :72-96
[8]  
Bangham C R, 1993, Trends Microbiol, V1, P260, DOI 10.1016/0966-842X(93)90048-V
[9]   Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-I [J].
Bangham, CRM ;
Hall, SE ;
Jeffery, KJM ;
Vine, AM ;
Witkover, A ;
Nowak, MA ;
Wodarz, D ;
Usuku, K ;
Osame, M .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 1999, 354 (1384) :691-700
[10]   Host cell-dependent alterations in envelope components of human immunodeficiency virus type 1 virions [J].
Bastiani, L ;
Laal, S ;
Kim, M ;
ZollaPazner, S .
JOURNAL OF VIROLOGY, 1997, 71 (05) :3444-3450